Finward Bancorp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
445
+90
+25% +$92K 0.4% 60
2026
Q1
$327K Hold
355
0.26% 76
2025
Q4
$382K Hold
355
0.3% 71
2025
Q3
$271K Sell
355
-40
-10% -$29.8K 0.21% 87
2025
Q2
$308K Hold
395
0.24% 83
2025
Q1
$326K Hold
395
0.28% 79
2024
Q4
$305K Buy
+395
New +$327K 0.26% 80

Other funds holding LLY

Finward Bancorp's LLY Position: Q2 2026 in Review

Finward Bancorp increased its Eli Lilly (LLY) stake by 25% in Q2 2026, buying an estimated $92K and bringing the position to 445 shares worth $534K. The position accounts for 0.4% of the portfolio, ranked #60.

Finward Bancorp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,176 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Finward Bancorp held 445 shares of Eli Lilly worth $534K as of Q2 2026.
  • Finward Bancorp bought 90 Eli Lilly shares in Q2 2026, an estimated $92K.
  • Eli Lilly made up 0.4% of Finward Bancorp's portfolio in Q2 2026, its #60 holding.
  • Finward Bancorp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Finward Bancorp's 13F filing for Q2 2026, filed 16 Jul 2026.